To test whether KIR or HLA are associated with differences in the course of disease we used a linear mixed model approach to model post-infection viral loads accounting for differences in times of viral load or CD4+ T-cell count measurement and inter-participant variation amongst 139 women. The gene discussed is CD4; the disease is infection.